Biodexa Pharmaceuticals Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	4.04	1.67	5.97	2.84	10.06	7.55
Cash & Short-Term Investments	4.04	1.67	5.97	2.84	10.06	7.55
Cash Growth	-20.16%	-72.05%	110.54%	-71.80%	33.28%	-30.95%
Accounts Receivable	4.49	0.01	-	0.33	0.03	0.1
Other Receivables	0.46	0.7	0.7	1.15	1.06	1.38
Receivables	4.96	0.72	0.7	1.48	1.1	1.47
Prepaid Expenses	-	6.43	0.36	0.38	0.61	0.26
Total Current Assets	8.99	8.81	7.03	4.69	11.76	9.28
Property, Plant & Equipment	0.19	0.32	0.57	0.83	1.15	0.54
Other Intangible Assets	5.65	5.65	2.94	0.01	-	-
Total Assets	14.82	14.78	10.54	5.53	12.91	9.82
Accounts Payable	1.41	0.71	0.31	0.34	0.49	0.34
Accrued Expenses	-	1.27	0.86	0.82	0.55	0.77
Short-Term Debt	0.5	0.43	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.11
Current Portion of Leases	-	0.18	0.17	0.16	0.15	0.09
Current Income Taxes Payable	-	0.05	0.06	0.08	0.06	0.03
Current Unearned Revenue	-	1.47	-	0.2	-	0.07
Other Current Liabilities	0.56	0.93	4.17	0.31	0.61	1.59
Total Current Liabilities	2.48	5.03	5.57	1.9	1.84	2.99
Long-Term Leases	-	0.12	0.3	0.46	0.62	0.06
Other Long-Term Liabilities	0.91	1.31	-	-	-	0.05
Total Liabilities	3.39	6.46	5.86	2.36	2.46	3.1
Common Stock	0.06	0.33	1.19	0.11	0.1	0.06
Additional Paid-In Capital	97.73	93.12	86.73	83.67	83.43	74.36
Retained Earnings	-154.13	-150.42	-144.77	-135.34	-127.8	-122.43
Comprehensive Income & Other	67.77	65.29	61.52	54.72	54.72	54.72
Shareholders' Equity	11.44	8.32	4.68	3.16	10.45	6.72
Total Liabilities & Equity	14.82	14.78	10.54	5.53	12.91	9.82
Total Debt	0.5	0.73	0.46	0.62	0.77	0.26
Net Cash (Debt)	3.54	0.94	5.51	2.21	9.29	7.29
Net Cash Growth	-24.35%	-82.89%	148.96%	-76.19%	27.52%	50.35%
Net Cash Per Share	22.17	19.02	-	-	-	-
Filing Date Shares Outstanding	0.62	0.26	0.02	-	-	-
Total Common Shares Outstanding	0.62	0.07	0.01	-	-	-
Working Capital	6.51	3.78	1.46	2.79	9.92	6.29
Book Value Per Share	18.46	124.47	393.24	-	-	-
Tangible Book Value	5.79	2.68	1.74	3.16	10.45	6.72
Tangible Book Value Per Share	9.35	40.02	146.02	-	-	-
Machinery	-	0.77	1.52	1.59	1.87	1.95
Leasehold Improvements	-	0.05	0.05	0.05	0.05	0

Updated Sep 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q